Compounded Sterile Preparations Intensives Studies (Cert #L259010)

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in:

• Selection and storage of sterile products, preparations, supplies, and equipment
• Best practices and processes for implementing media-fill testing in multi-site compounding operations
• Pediatric compounding conundrums
• Evaluating stability-indicating analytical methods in primary literature

Board certified pharmacists are eligible to receive up to 4.0 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline.   

ASHP provides an opportunity for remediation. Participants who are unsuccessful with the first assessment attempt may take a second assessment. The second assessment is included at no additional cost.

ASHP is approved by BPS as a provider for the recertification of BCSCP.

Compounding:  All the Components
ACPE #: 0204-0000-24-213-H07-P

• Describe appropriate parameters for selection and storage of sterile products, preparations, supplies, and equipment.
• Evaluate supplies and equipment used for sterile compounding.
• Describe resources and expectations for outsourced sterile compounding organizations. 

USP <797>: Navigating Process Simulations and Media Fill Testing in Multi-Site Health Systems
ACPE #: 0204-0000-24-234-H07-P

• Describe the purpose and utility of aseptic processing simulations and media-fill testing.
• Outline approach for determining ‘the most difficult and challenging aseptic procedures’ in practice and documenting in standard operating procedures.
• Evaluate components used for designing an effective aseptic processing simulation.
• Apply best practices for implementing media-fill testing in multi-site compounding operations. 

Pediatric Compounding Conundrums: Just Keep Swimming
ACPE #: 0204-0000-24-236-H07-P

• Categorize stability assignments for sterile preparations adjusted to meet pediatric patient needs.
• Predict the impact of IV workflow and automatic limits on preparing pediatric doses.
• Assign beyond use dates for products prepared from stock solutions. 

Supporting Evidence for Beyond Use Dates: Evaluating Stability-Indicating Analytical Methods in Primary Literature
ACPE #: 0204-0000-24-247-H07-P

• Discuss master formulation record requirements to support beyond use date assignment for Category 1, 2, and 3 compounded sterile products.
• Identify stability-indicating analytical methods in primary literature.
• Given examples, demonstrate the application of bracketing to assign an appropriately supported beyond use date to a range of concentrations. 

Full faculty bios 

Cindy Brasher, PharmD, MS, BCSCP
Manager of Compounding
St. Jude Children's Research Hospital 

Kevin N. Hansen, PharmD, MS, BCSCP
Director, 503B Program
Premier

Patricia C. Kienle, RPh, MPA, BCSCP, FASHP
Director, Accreditation and Medication Safety
Cardinal Health 

Melissa L. Messick, PharmD, BCNSP, BCSCP
Manager, Inpatient Sterile Products
Penn State Health/Milton S Hershey Medical Center 

Jamie Tharp, PharmD, BCSCP
Assistant Director of Pharmacy Compounding Compliance
University of Michigan Health

Sue Dombrowski, MS, RPh
Angela Cassano, PharmD, BCPS*
Kevin N. Hansen, PharmD, MS, BCSCP*
Patricia C. Kienle, RPh, MPA, BCSCP, FASHP*

Ghassan Agha, MAT, PharmD, RPh, BCNP, BCSCP
Ben Amosah, PharmD, BCSCP
Carla Evans, PharmD, BCSCP
Dawn Feret, RPh, MBA, BCSCP
Donald Filibeck, PharmD, BCSCP
Michael Freudiger, PharmD, APh, BCPS, BCSCP
Alesia Hanson, RPh, BCSCP
Amanda Harding, PharmD, BCSCP
Kimberly Haverstick, PharmD, MBA, BCSCP
Shawn Hegner, PharmD, BCSCP
Eileen Hendrickson, BSPharm, PharmD, MBA, BCSCP
Allison Hoff, BS Pharm, BCSCP
Mohamed Khaleelullah Khan, BPharm, BCSCP
Susan Kleppin, RPH, BCSCP
Ruth Link, PharmD, BCSCP
Robert MacArthur, PharmD, BCSCP
James Mason, PharmD, MS, BCSCP, RAC
Fred Massoomi, PharmD, BCSCP, FASHP
Pamela Mathis, PharmD, BCSCP
Kristen McCloy, PharmD, BCSCP, IgCP
Helen McKnight, PharmD, MBA, BCSCP
Kathleen McTernan, PharmD, BCSCP
Melissa Messick, PharmD, BCNSP, BCSCP
Thu-Trang "Lucy" Nguyen, PharmD, BCSCP
Barbara Petroff, MS, RPh, BCSCP, FASHP, FNHIA
Christine Riat, PharmD, BCSCP
Catherine Richwine, BS, BCSCP
Arpita Sammons, PharmD, BCSCP
Elizabeth Schar, BS Pharm, PLA, BCSCP
George Smith, PharmD, BCPS, BCSCP
Jill Smitherman, BSPharm, BCSCP
Kathy Stone, PharmD, BCSCP
Lori Watts, RPh, BCSCP
Stacy Wong, PharmD, MSHS, BCSCP

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

Activities consist of educational materials, assessments, and activity evaluations. In order to receive continuing pharmacy education credit, learners must:

• Complete the attestation statement
• Review all content
• Complete and pass the assessments
• Complete the evaluations 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

These activities were developed by ASHP.